AlconALC +2.74%71 EV-to-FCF is 23.00 as of Jun. 24, 2026, which is 78% below its 10-year median of 106.06. GuruFocus rates ALC with a GF Score™ of 71/100 and a GF Value™ of $90.79 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Alcon ranks better than 50.48% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alcon's Enterprise Value is $36,597 Mil.
Alcon's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $1,591 Mil. Therefore, Alcon's EV-to-FCF for today is 23.00.
The historical rank and industry rank for Alcon's EV-to-FCF or its related term are showing as below:
ALC'
s EV-to-FCF Range Over the Past 10 Years
Min: -292.42 Med: 106.06 Max: 829.7
Current: 23
During the past 10 years, the highest EV-to-FCF of Alcon was 829.70. The lowest was -292.42. And the median was 106.06.
ALC's EV-to-FCF is ranked better than 50.48% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 22.66
vs ALC: 23.00
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-06-24), Alcon's stock price is $67.93.
Alcon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $1.660. Therefore, Alcon's PE Ratio (TTM) for today is 40.92.
Alcon (NYSE:ALC) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alcon's share price for today is $67.93.
Alcon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.660.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Alcon EV-to-FCF Related Terms
Alcon EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Alcon's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Alcon's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcon EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alcon's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Alcon's EV-to-FCF falls into.
Alcon's current Enterprise Value is $36,597 Mil.
Alcon's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,591 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcon (ALC) has a EV-to-FCF of 23.00 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Alcon and its competitors. This is 78% below median its historical median of 106.06. According to the industry distribution chart, Alcon ranks #207 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 49.5%.
Is Alcon's EV-to-FCF too high?
Alcon's current EV-to-FCF of 23.00 is 78% below median its 10-year median of 106.06. The Medical Devices & Instruments industry median EV-to-FCF is 22.66. Alcon's value of 23.00 is 1.5% above this industry median. Based on the distribution chart, Alcon ranks #207 out of 418 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Alcon has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Alcon ranks #207 out of 418 companies for EV-to-FCF. This puts Alcon in the upper half of its industry. The industry median EV-to-FCF is 22.66. Alcon's value of 23.00 is 1.5% above this benchmark. While the company's 10-year median is 106.06 vs. the industry median of 22.66, Alcon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.66, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current EV-to-FCF of 23.00 is 1.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Alcon and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current EV-to-FCF is 23.00, which is 78% below median its own 10-year median of 106.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is $90.79, compared to a current price of $67.93 — trading 25.2% below its estimated fair value. The current EV-to-FCF is 23.00, which is 78% below median its 10-year median of 106.06 and 1.5% above the Medical Devices & Instruments industry median of 22.66. Alcon's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Alcon (ALC), the current EV-to-FCF is 23.00 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcon (ALC) Overvalued in 2026?
Based on GuruFocus' analysis, Alcon stock appears to be undervalued.
The current stock price of $67.93 is trading 25.2% below its estimated GF Value™ of $90.79.
GuruFocus considers Alcon to be Modestly Undervalued.
Key valuation signals for ALC:
EV-to-FCF: 23.00 (78% below median its 10-year median of 106.06)
GF Value™: $90.79 vs. price of $67.93 (25.2% below fair value)
Industry Position: 1.5% above the Medical Devices & Instruments median (#207 of 418)
No single metric tells the full story. See the ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
71GF Score
Get the complete analysis for ALC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALC has been successfully added to your 
